BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19789299)

  • 1. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis.
    Syed Z; Cheepala SB; Gill JN; Stein J; Nathan C; Digiovanni J; Batra V; Adegboyega P; Kleiner HE; Clifford JL
    Cancer Prev Res (Phila); 2009 Oct; 2(10):903-11. PubMed ID: 19789299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
    Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
    Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.
    Cheepala SB; Yin W; Syed Z; Gill JN; McMillian A; Kleiner HE; Lynch M; Loganantharaj R; Trutschl M; Cvek U; Clifford JL
    Mol Cancer; 2009 May; 8():27. PubMed ID: 19432991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids and skin: microarrays shed new light on chemopreventive action of all-trans retinoic acid.
    Cheepala SB; Syed Z; Trutschl M; Cvek U; Clifford JL
    Mol Carcinog; 2007 Aug; 46(8):634-9. PubMed ID: 17538947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction.
    Yasuda M; Nishizawa T; Ohigashi H; Tanaka T; Hou DX; Colburn NH; Murakami A
    Carcinogenesis; 2009 Jul; 30(7):1209-16. PubMed ID: 19414503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes.
    Quadros MR; Peruzzi F; Kari C; Rodeck U
    Cancer Res; 2004 Jun; 64(11):3934-9. PubMed ID: 15173005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases.
    Sano S; Chan KS; DiGiovanni J
    J Dermatol Sci; 2008 Apr; 50(1):1-14. PubMed ID: 17601706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3.
    Aziz MH; Manoharan HT; Verma AK
    Cancer Res; 2007 Feb; 67(3):1385-94. PubMed ID: 17283176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
    Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
    Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA; Wilhelm S; Carter C; Kelley SL
    Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice.
    Lai CS; Li S; Chai CY; Lo CY; Ho CT; Wang YJ; Pan MH
    Carcinogenesis; 2007 Dec; 28(12):2581-8. PubMed ID: 17962218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis.
    Kim DJ; Chan KS; Sano S; Digiovanni J
    Mol Carcinog; 2007 Aug; 46(8):725-31. PubMed ID: 17610223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
    Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
    Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines.
    Sumita N; Bito T; Nakajima K; Nishigori C
    Exp Dermatol; 2006 Apr; 15(4):291-9. PubMed ID: 16512876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis.
    Kataoka K; Kim DJ; Carbajal S; Clifford JL; DiGiovanni J
    Carcinogenesis; 2008 Jun; 29(6):1108-14. PubMed ID: 18453544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice.
    Chen N; Nomura M; She QB; Ma WY; Bode AM; Wang L; Flavell RA; Dong Z
    Cancer Res; 2001 May; 61(10):3908-12. PubMed ID: 11358804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suprabasal BCL-2 expression does not sensitize to chemically-induced skin cancer in transgenic mice.
    Schenkel J; Weiher H; Fürstenberger G; Jäger R
    Anticancer Res; 2008; 28(5A):2825-9. PubMed ID: 19035317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.